课题基金 / 基金详情

Identification of activating factors for signal transduction released during ischemia in heart

Identification of activating factors for signal transduction released during ischemia in heart
心脏缺血期间释放的信号转导激活因子的鉴定
批准号:
13832005
负责人:
MIZUKAMI Yoichi
金额:
$2.37万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

MIZUKAMI Yoichi的其他基金

相似基金

相关文献

中文摘要
翻译
我们从缺血心肌细胞中纯化释放的存活因子。取培养心肌细胞上清100升,硫酸铵浓缩。用柱层析法分离样品,检测心肌细胞的存活活性。用质谱法鉴定了两种具有存活活性的蛋白。这些蛋白的分子质量分别为33 kDa和41 kDa。这些蛋白诱导30kda蛋白丝氨酸磷酸化,纯化后的蛋白表现出存活活性。我们推测这些蛋白在了解心脏缺血和药物开发中发挥作用。
英文摘要
We purify survival factors released from cadiomyocytes exposed to ischemia. The supernatant of 100 liter was collected from cultured cardiomyocytes, and concentrated by ammonium sulfate. The sample was separated by column chromatography, and tested survival activity for cardiomyocytes. Two proteins having survival activity were identified using mass spectrometry. The molecular masses of these proteins are 33 kDa and 41 kDa, respectively. These proteins induce serine phosphorylation of 30 kDa protein, and the purified proteins show survival activity. We speculate that these proteins play a role for understanding of ischemia in heart and for development of drug discovery.
期刊论文(31)
专著(0)
科研奖励(0)
会议论文
Shirao, S.: "Sphingophosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C"Circ. Res.. 91(2). 112-119 (2002)
Shirao, S.:“鞘氨醇磷酰胆碱是牛大脑动脉中 Rho 激酶介导的 Ca2 敏化的新型信使:对蛋白激酶 C 的作用不重要”Circ.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujimoto, K., et al.: "Molecular cloning of rat transmembrane domain 40-kDa regulated in adipocytes and its expression in H9c2 cells exposed to ischemic hypoxia and reoxygenation"Biochim.Biophys.Acta.(Gene Structure & Expression). 1518. 173-177 (2001)
Fujimoto, K. 等人:“脂肪细胞中调节的大鼠跨膜结构域 40-kDa 的分子克隆及其在暴露于缺血性缺氧和复氧的 H9c2 细胞中的表达”Biochim.Biophys.Acta.(基因结构)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakao, F., et al.: "Involvement of Src Family Protein Tyrosine Kinases in Ca2+-Sensitization of Coronary Artery Contraction Mediated by a Sphingosylphosphorylcholine-Rho-Kinase Pathway"Circ.Res.. 91. 953-960 (2002)
Nakao,F.等人:“Src家族蛋白酪氨酸激酶参与Ca2-由鞘氨醇磷酸胆碱-Rho-激酶途径介导的冠状动脉收缩的敏化”Circ.Res.. 91. 953-960 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Elucidation of cardiomyopathy caused by gene mutations induced environmental stresses -exhaustive mutation analysis and genome editing-genome
    • 批准号:
      15K08210
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2015
    • 负责人:
      MIZUKAMI Yoichi
    • 依托单位:
    Identification of master molecules in signal transduction of canceled cells using TAT protein
    • 批准号:
      24590301
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      MIZUKAMI Yoichi
    • 依托单位:
    High throughput screening for G protein-coupled receptor(s) activated in response to estrogen by RNAi collection
    • 批准号:
      21590256
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      MIZUKAMI Yoichi
    • 依托单位:
    A novelestrogen receptor in plasma membrane
    • 批准号:
      18590205
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      MIZUKAMI Yoichi
    • 依托单位:
    国内基金
    海外基金
    缺氧诱导因子(HIF)-2α转录抑制树突状细胞CD36表达减轻肾脏缺血再灌注损伤的机制
    • 批准号:
      82370751
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      张明
    • 依托单位:
    骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
    • 批准号:
      82371301
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李轶
    • 依托单位:
    TRIM21蛋白促进HIF1α的降解介导耳蜗血管纹缘细胞缺血再灌注致听力损伤的机制研究
    • 批准号:
      82371142
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      刘君
    • 依托单位:
    基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题